STARC: Difference between revisions

Latest revision as of 03:52, 21 August 2013

Redirect to:

Revision as of 19:25, 6 July 2009 (view source) DaveBot (talk \| contribs) (Redirecting 'STARC' to 'Angioplasty/Atherectomy/Laser Therapy: Trapidil (Triazolopyrimidine), A Platelet-Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results Of The Randomized, Double-Blin)		Latest revision as of 03:52, 21 August 2013 (view source) Vendhan Ramanujam (talk \| contribs) No edit summary
Line 1:		Line 1:
	#REDIRECT [[Angioplasty/Atherectomy/Laser Therapy: Trapidil (Triazolopyrimidine), A Platelet-Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results Of The Randomized, Double-Blind Starc Study]]		#REDIRECT [[Angioplasty/Atherectomy/Laser Therapy: Trapidil (Triazolopyrimidine), A Platelet-Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results Of The Randomized, Double-Blind Starc Study]]

			[[Category:Clinical trials]]